» Articles » PMID: 31461648

UCP2 Deficiency Increases Colon Tumorigenesis by Promoting Lipid Synthesis and Depleting NADPH for Antioxidant Defenses

Abstract

Colorectal cancer (CRC) is associated with metabolic and redox perturbation. The mitochondrial transporter uncoupling protein 2 (UCP2) controls cell proliferation in vitro through the modulation of cellular metabolism, but the underlying mechanism in tumors in vivo remains unexplored. Using murine intestinal cancer models and CRC patient samples, we find higher UCP2 protein levels in tumors compared to their non-tumoral counterparts. We reveal the tumor-suppressive role of UCP2 as its deletion enhances colon and small intestinal tumorigenesis in AOM/DSS-treated and Apc mice, respectively, and correlates with poor survival in the latter model. Mechanistically, UCP2 loss increases levels of oxidized glutathione and proteins in tumors. UCP2 deficiency alters glycolytic pathways while promoting phospholipid synthesis, thereby limiting the availability of NADPH for buffering oxidative stress. We show that UCP2 loss renders colon cells more prone to malignant transformation through metabolic reprogramming and perturbation of redox homeostasis and could favor worse outcomes in CRC.

Citing Articles

The Role of Mitochondrial Solute Carriers SLC25 in Cancer Metabolic Reprogramming: Current Insights and Future Perspectives.

Ahmed A, Iaconisi G, Di Molfetta D, Coppola V, Caponio A, Singh A Int J Mol Sci. 2025; 26(1.

PMID: 39795950 PMC: 11719790. DOI: 10.3390/ijms26010092.


UCP2, a Member of the Mitochondrial Uncoupling Proteins: An Overview from Physiological to Pathological Roles.

Nesci S, Rubattu S Biomedicines. 2024; 12(6).

PMID: 38927514 PMC: 11201685. DOI: 10.3390/biomedicines12061307.


A New Strategy for Targeting UCP2 to Modulate Glycolytic Reprogramming as a Treatment for Sepsis A New Strategy for Targeting UCP2.

Li N, Deng J, Zhang J, Yu F, Ye F, Hao L Inflammation. 2024; 47(5):1634-1647.

PMID: 38429403 PMC: 11549132. DOI: 10.1007/s10753-024-01998-4.


UCP2 and pancreatic cancer: conscious uncoupling for therapeutic effect.

Caggiano E, Taniguchi C Cancer Metastasis Rev. 2024; 43(2):777-794.

PMID: 38194152 PMC: 11156755. DOI: 10.1007/s10555-023-10157-4.


Chemopreventive Effects of Polysaccharides and Flavonoids from Okra Flowers in Azomethane/Dextran Sulfate Sodium-Induced Murine Colitis-Associated Cancer.

Deng Y, Huang X, Chen X, Wang M, Tian L, Zhou H Nutrients. 2023; 15(22).

PMID: 38004214 PMC: 10674164. DOI: 10.3390/nu15224820.


References
1.
Sciuto A, Moran T . BHA diet enhances the survival of mice exposed to phosgene: the effect of BHA on glutathione levels in the lung. Inhal Toxicol. 1999; 11(9):855-71. DOI: 10.1080/089583799196772. View

2.
Pecqueur C, Alves-Guerra M, Gelly C, Levi-Meyrueis C, Couplan E, Collins S . Uncoupling protein 2, in vivo distribution, induction upon oxidative stress, and evidence for translational regulation. J Biol Chem. 2000; 276(12):8705-12. DOI: 10.1074/jbc.M006938200. View

3.
Arsenijevic D, Onuma H, Pecqueur C, Raimbault S, Manning B, Miroux B . Disruption of the uncoupling protein-2 gene in mice reveals a role in immunity and reactive oxygen species production. Nat Genet. 2000; 26(4):435-9. DOI: 10.1038/82565. View

4.
Couplan E, Gonzalez-Barroso M, Ricquier D, Goubern M, Bouillaud F . No evidence for a basal, retinoic, or superoxide-induced uncoupling activity of the uncoupling protein 2 present in spleen or lung mitochondria. J Biol Chem. 2002; 277(29):26268-75. DOI: 10.1074/jbc.M202535200. View

5.
Blanc J, Alves-Guerra M, Esposito B, Rousset S, Gourdy P, Ricquier D . Protective role of uncoupling protein 2 in atherosclerosis. Circulation. 2003; 107(3):388-90. DOI: 10.1161/01.cir.0000051722.66074.60. View